Latest period
$1.12B
YoY change
+13.8%
5Y CAGR
+3.1%
Peak year (2025)
$1.09B
Latest annual
$1.09B
Total Liabilities history chart for West Pharmaceutical Services (WST) from 1985 to 2025
Latest: $1.09B
Total Liabilities growth chart for West Pharmaceutical Services (WST) from 1985 to 2025
Latest: +13.8%
Total Liabilities history table for West Pharmaceutical Services (WST) from 1985 to 2025
| 2025 | $1.09B | +13.8% | +$132.90M | ||
| 2024 | $961.10M | +1.3% | +$12.60M | ||
| 2023 | $948.50M | +1.8% | +$16.60M | ||
| 2022 | $931.90M | -4.8% | −$46.50M | ||
| 2021 | $978.40M | +4.2% | +$39.10M | ||
| 2020 | $939.30M | +22.3% | +$171.10M | ||
| 2019 | $768.20M | +31.9% | +$185.60M | ||
| 2018 | $582.60M | -0.1% | −$300.00K | ||
| 2017 | $582.90M | -2.7% | −$16.30M | ||
| 2016 | $599.20M | -10.7% | −$72.00M | ||
| 2015 | $671.20M | -5.8% | −$41.60M | ||
| 2014 | $712.80M | -6.8% | −$52.40M | ||
| 2013 | $765.20M | -8.4% | −$69.90M | ||
| 2012 | $835.10M | +12.2% | +$90.90M | ||
| 2011 | $744.20M | +11.3% | +$75.60M | ||
| 2010 | $668.60M | -3.4% | −$23.30M | ||
| 2009 | $691.90M | +1.5% | +$10.30M | ||
| 2008 | $681.60M | -1.9% | −$13.10M | ||
| 2007 | $694.70M | +39.2% | +$195.80M | ||
| 2006 | $498.90M | +1.9% | +$9.40M | ||
| 2005 | $489.50M | +40.6% | +$141.40M | ||
| 2004 | $348.10M | -4.9% | −$17.90M | ||
| 2003 | $366.00M | +11.6% | +$37.90M | ||
| 2002 | $328.10M | -1.9% | −$6.40M | ||
| 2001 | $334.50M | -2.6% | −$8.80M | ||
| 2000 | $343.30M | +7.3% | +$23.50M | ||
| 1999 | $319.80M | +15.3% | +$42.40M | ||
| 1998 | $277.40M | +38.8% | +$77.60M | ||
| 1997 | $199.80M | -11.2% | −$25.30M | ||
| 1996 | $225.10M | -0.3% | −$700.00K | ||
| 1995 | $225.80M | +34.2% | +$57.60M | ||
| 1994 | $168.20M | +55.2% | +$59.80M | ||
| 1993 | $108.40M | -13.8% | −$17.30M | ||
| 1992 | $125.70M | -17.4% | −$26.40M | ||
| 1991 | $152.10M | -2.3% | −$3.60M | ||
| 1990 | $155.70M | +25.4% | +$31.50M | ||
| 1989 | $124.20M | -2.6% | −$3.30M | ||
| 1988 | $127.50M | +2.6% | +$3.20M | ||
| 1987 | $124.30M | +26.2% | +$25.80M | ||
| 1986 | $98.50M | +65.5% | +$39.00M | ||
| 1985 | $59.50M | — | — |
- 2025$1.09B+13.8%
- 2024$961.10M+1.3%
- 2023$948.50M+1.8%
- 2022$931.90M-4.8%
- 2021$978.40M+4.2%
- 2020$939.30M+22.3%
- 2019$768.20M+31.9%
- 2018$582.60M-0.1%
- 2017$582.90M-2.7%
- 2016$599.20M-10.7%
- 2015$671.20M-5.8%
- 2014$712.80M-6.8%
- 2013$765.20M-8.4%
- 2012$835.10M+12.2%
- 2011$744.20M+11.3%
- 2010$668.60M-3.4%
- 2009$691.90M+1.5%
- 2008$681.60M-1.9%
- 2007$694.70M+39.2%
- 2006$498.90M+1.9%
- 2005$489.50M+40.6%
- 2004$348.10M-4.9%
- 2003$366.00M+11.6%
- 2002$328.10M-1.9%
- 2001$334.50M-2.6%
- 2000$343.30M+7.3%
- 1999$319.80M+15.3%
- 1998$277.40M+38.8%
- 1997$199.80M-11.2%
- 1996$225.10M-0.3%
- 1995$225.80M+34.2%
- 1994$168.20M+55.2%
- 1993$108.40M-13.8%
- 1992$125.70M-17.4%
- 1991$152.10M-2.3%
- 1990$155.70M+25.4%
- 1989$124.20M-2.6%
- 1988$127.50M+2.6%
- 1987$124.30M+26.2%
- 1986$98.50M+65.5%
- 1985$59.50M—
Total Liabilities values are taken from West Pharmaceutical Services's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Liabilities at West Pharmaceutical Services (WST)
According to West Pharmaceutical Services's latest reported financial statements, the company's latest reported total liabilities is $1.12B. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and total equity for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual total liabilities for West Pharmaceutical Services (WST) came in at $1.09B – grew 13.8% year-over-year.
Looking at the 2020–2025 (5 years) stretch, West Pharmaceutical Services total liabilities compounded at +3.1% per year, with mixed annual results across the window.
Across the available history, total liabilities reached its high of $1.09B in 2025 and its low of $59.50M in 1985.
West Pharmaceutical Services Total Liabilities by Year
West Pharmaceutical Services Total Liabilities 2025: $1.09B
In 2025, West Pharmaceutical Services reported total liabilities of $1.09B, grew 13.8% from 2024. This figure represents the highest annual value in the available history.
West Pharmaceutical Services Total Liabilities 2024: $961.10M
West Pharmaceutical Services total liabilities in 2024 was $961.10M, edged up 1.3% from 2023.
West Pharmaceutical Services Total Liabilities 2023: $948.50M
2023's total liabilities for West Pharmaceutical Services came in at $948.50M, edged up 1.8% from 2022.
West Pharmaceutical Services Total Liabilities 2022: $931.90M
West Pharmaceutical Services posted total liabilities of $931.90M in 2022, edged down 4.8% below 2021.
West Pharmaceutical Services Total Liabilities 2021: $978.40M
West Pharmaceutical Services total liabilities in 2021 was $978.40M.
See more financial history for West Pharmaceutical Services (WST).
Sector peers by Total Liabilities
Healthcare peers of West Pharmaceutical Services (WST), ranked by their latest total liabilities
| $207.88B | |
| $137.19B | |
| $117.67B | |
| $85.94B | |
| $84.20B | |
| $81.93B | |
| $65.36B | |
| $54.86B |
- $207.88B
- $137.19B
- $117.67B
- $85.94B
- $84.20B
- $81.93B
- $65.36B
- $54.86B
Frequently asked questions
West Pharmaceutical Services (WST) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation